These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8100656)

  • 1. Immunohistochemical study of neu protein overexpression in clinging in situ duct carcinoma of the breast.
    De Potter CR; Foschini MP; Schelfhout AM; Schroeter CA; Eusebi V
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):375-80. PubMed ID: 8100656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ.
    Bartkova J; Barnes DM; Millis RR; Gullick WJ
    Hum Pathol; 1990 Nov; 21(11):1164-7. PubMed ID: 1977679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?
    Barnes DM; Bartkova J; Camplejohn RS; Gullick WJ; Smith PJ; Millis RR
    Eur J Cancer; 1992; 28(2-3):644-8. PubMed ID: 1350456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia.
    Porter PL; Garcia R; Moe R; Corwin DJ; Gown AM
    Cancer; 1991 Jul; 68(2):331-4. PubMed ID: 1676930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
    van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R
    N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.
    Wilbur DC; Barrows GH
    Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity.
    Zafrani B; Leroyer A; Fourquet A; Laurent M; Trophilme D; Validire P; Sastre-Garau X
    Semin Diagn Pathol; 1994 Aug; 11(3):208-14. PubMed ID: 7831532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The classification of ductal carcinoma in situ and its association with biological markers.
    Bobrow LG; Happerfield LC; Gregory WM; Springall RD; Millis RR
    Semin Diagn Pathol; 1994 Aug; 11(3):199-207. PubMed ID: 7831531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast.
    Lilleng R; Hagmar BM; Nesland JM
    Mod Pathol; 1992 Jan; 5(1):41-7. PubMed ID: 1347423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53 protein in infiltrating and in-situ breast carcinomas.
    Walker RA; Dearing SJ; Lane DP; Varley JM
    J Pathol; 1991 Nov; 165(3):203-11. PubMed ID: 1684809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
    Tsang WY; Chan JK
    Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma.
    Eusebi V; Foschini MP; Cook MG; Berrino F; Azzopardi JG
    Semin Diagn Pathol; 1989 May; 6(2):165-73. PubMed ID: 2548274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.
    Allred DC; Clark GM; Molina R; Tandon AK; Schnitt SJ; Gilchrist KW; Osborne CK; Tormey DC; McGuire WL
    Hum Pathol; 1992 Sep; 23(9):974-9. PubMed ID: 1355464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
    Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
    Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
    Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of in situ carcinoma of the breast.
    Eusebi V; Feudale E; Foschini MP; Micheli A; Conti A; Riva C; Di Palma S; Rilke F
    Semin Diagn Pathol; 1994 Aug; 11(3):223-35. PubMed ID: 7831534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer.
    Gusterson BA; Machin LG; Gullick WJ; Gibbs NM; Powles TJ; Price P; McKinna A; Harrison S
    Int J Cancer; 1988 Dec; 42(6):842-5. PubMed ID: 2903851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade cribriform ductal carcinoma in situ of the breast. Fine needle aspiration cytology in three cases.
    Lilleng R; Hagmar BM; Farrants G
    Acta Cytol; 1992; 36(1):48-54. PubMed ID: 1312285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK; Tjan S; Parkes RK; O'Malley FP
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.